Our team is committed to advancing genomic medicine.
Led by renowned experts in the fields of genomics, epigenetic editing, and drug discovery, we are driven pioneers committed to making the future of genomic medicine real and delivering hope to patients suffering from serious illnesses.
Catherine Stehman-Breen, M.D., M.S.
Chief Executive Officer
Vic Myer, Ph.D.
President and Chief Scientific Officer
Brett Kaplan, M.D., M.B.A.
Chief Financial and Corporate Development Officer
Aron Jaffe, Ph.D.
Senior Vice President, Head of Research
Senior Vice President, People and Culture
Senior Vice President, Business Development
Senior Vice President, Delivery Sciences and CMC
Andrea Sarasin, Ph.D.
Vice President, Business Strategy and Integration
Cecilia Fernandez, Ph.D., M.B.A.
Vice President, Strategic Planning and Operations
Tobias Brambrink, J.D.
Vice President, Intellectual Property
Vice President, Program Management